Skip to main content

Table 1 Patients characteristics

From: Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1

Parameters Ovarian cancer Control
Material (type) Blood Ascites Tumour tissue Blood
Subjects, n 43 26 29 15
Age (years), med (min–max) 60 (20–86) 69 (20–86) 52 (20–80) 57 (34–64)
Stage, n (%) NA
 Early (I/II) 20 (46.5) 6 (23.1) 17 (58.6)
 Advanced (III/IV) 23 (53.5) 20 (76.9) 12 (41.4)
Grade, n (%)
 GII 24 (55.8) 13 (50.0) 11 (37.9)
 GIII 19 (44.20 13 (50.0) 18 (62.1)
Kurman and Shih’s type, n (%)
 I 28 (65.1) 13 (50.0) 21 (72.4)
 II 15 (34.9) 13 (50.0) 8 (27.6)
Histology, n (%)
 Endometrioid 21 (48.8) 7 (26.9) 16 (55.2)
 Serous 18 (41.9) 13 (50.0) 9 (31.0)
 Mucinous 4 (9.3) 6 (23.1) 4 (13.8)
  1. NA not applicable